Learn

The 2024 Schedule at a Glance is now available.

Podium presentations will be organized into three educational tracks: Frontiers in Technology, Screening Applications & Diagnostics and Shaping the Future of Therapeutics. Track descriptions are listed below. Session titles will be updated in Spring 2024.

Frontiers in Technology
This track will feature presentations by renowned experts and innovators, including those from organizations like ELRIG, who are at the forefront of leveraging advanced technologies to significantly enhance laboratory screening, automation, and analysis. These technological advancements will be pivotal in driving scientific discovery forward. Moreover, the increasing volume of data generated from Omics, High Content Screening (HCS), drug discovery, and sample management has catalyzed the development of cutting-edge algorithms rooted in big data analytics and machine learning/artificial intelligence. Attendees can anticipate gaining valuable insights into the latest technological breakthroughs that have the potential to revolutionize their businesses and streamline their processes.

Co-chairs: Patricia Maguire (University College Dublin) and Mike Gray (GlaxoSmithKline)

Screening Applications & Diagnostics
This track aims to provide a clear view on how diagnostics and screening applications are evolving by taking into the account the medical and scientific challenges arising in the post-covid era. This track will host renowned experts and innovators who will guide us through the latest technologies and breakthroughs that are influencing emerging topics. Topics will include new testing paradigms which are closer to patients (point-of-care or at-home testing), new automation technologies, sequencing of the human genome, and how AI and machine learning can help address global emerging threats such as anti-microbial resistance, anti-biotic massive abuse, and sepsis management. Attendees can expect unique insights and hints on the latest technological innovations, whilst our experts and innovators will shed more light on key trends that we should look for in the coming years.

Co-chairs: Ricard Martin (Qiagen) and Dominik Rubus (Rabus.Tech)

Shaping the Future of Therapeutics
This track aims to provide a better understanding of current approaches that significantly impact the journey of novel medicines from scientific discoveries to patient treatment. Over four sessions, you will explore how the combination of big data and artificial intelligence is transforming the traditional drug discovery process. Additionally, we will delve into how personalized medicine and drug repurposing influence patient outcomes. We'll also discuss the future of safety, toxicology and efficacy studies in light of the FDA's recent decision to eliminate the requirement for animal testing. Finally, we will present the advantages and challenges in the discovery and delivery of oligo therapeutics.

Co-chairs: Magdalena Otrocka (Ardigen) and Annika Jenmalm Jensen (Karolinska Institutet)